Vaccine News and Research

Latest Vaccine News and Research

EuroVacc 02 HIV Vaccine trial begins

The European Vaccine Effort against HIV/AIDS, has announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005.

16 Feb 2005

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B Virus (HBV), an acute sometimes fatal form of viral hepatitis caused by a DNA virus that persists in the blood serum and is transmitted by sexual contact or by transfusion or by ingestion of contaminated blood or other bodily fluids.

14 Feb 2005

Vaccination Week, largest immunization drive in the Americas

Health workers in every country in the Western Hemisphere are preparing strategies, purchasing vaccines, and coordinating logistics for the largest immunization drive in the Americas, targeting millions of children for Vaccination Week in the Americas, starting April 23.

13 Feb 2005

Preventive measures are failing to stem the rising rate of HIV infection

An estimated 38 million people worldwide, including over 2 million children, are now infected with HIV, and a record 4.8 million became infected in 2003.

10 Feb 2005

PAHO vaccines books wins major award

The Pan American Health Organization’s publication, Vaccines: Preventing Disease and Protecting Health, has won an award from the Association of American Publishers in the medical science category.

9 Feb 2005

Merck may have known the overuse of mercury in their vaccines posed a dangerous health threat to children

A Los Angeles Times article today reports that Merck, a leading manufacturer of prescription drugs, knew the overuse of mercury in their vaccines posed a dangerous health threat to children.

8 Feb 2005

India trials investigational vaccine candidate designed to prevent HIV/AIDS

Announcing the trial, Union Minister of Health and Family Welfare Dr. Anbumani Ramadoss, said: "Developing a vaccine to prevent AIDS is one of the most difficult scientific challenges of our time. It is also one of the most urgent health needs. Perseverance is the way forward, and India has a long- term commitment."

7 Feb 2005

Parents comfortable with vaccination for STIs for their children

Parents are generally accepting of the hypothetical scenario of vaccinating their adolescent children against infection, whether the infection is sexually transmitted or not, according to a study in the February issue of The Archives of Pediatrics and Adolescent Medicine.

7 Feb 2005

Varicella vaccine is almost 90 percent effective against chickenpox

The varicella vaccine is almost 90 percent effective against chickenpox, but its impact on herpes zoster (shingles) is unknown and needs wider surveillance, Yale School of Medicine researchers write in today's New England Journal of Medicine (NEJM) perspective section.

7 Feb 2005

Eleventh Edition of the Report on Carcinogens

The Department of Health and Human Services released its Eleventh Edition of the Report on Carcinogens today, adding seventeen substances to the growing list of cancer-causing agents, bringing the total to 246.

31 Jan 2005

Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

As new technologies are innovated in the pharmaceutical and biotechnology sectors, the number of fresh patents and related regulations is also on the rise.

31 Jan 2005

Clinical trials to test the safety of a first-of-its-kind human hookworm vaccine

Clinical trials to test the safety of a first-of-its-kind human hookworm vaccine will begin in the Washington, DC area in a couple of months after the U.S. Food and Drug Administration conferred investigational new drug status on the vaccine.

27 Jan 2005

Basis for deciding cost effectiveness of TB vaccination programmes questioned

Current risk assessment methods, which are used to inform the timing and extent of tuberculosis (TB) vaccination programmes, may overestimate the real risk of contracting the disease up to threefold, reveals research in Thorax.

26 Jan 2005

Bill & Melinda give $750 million for vaccines and immunization

The Bill & Melinda Gates Foundation announced a grant of $750 million, and Norway committed $290 million, to support the work of the Global Alliance for Vaccines and Immunization (GAVI).

25 Jan 2005

New technique can greatly facilitate the development of vaccines against infectious diseases such as smallpox, malaria and tuberculosis

Because the new technique can synthesize a large number of proteins very quickly, it has potential to accelerate vaccine development, particularly crucial in the fight against bioterrorism.

25 Jan 2005

School influenza vaccinations best strategy for slowing flu transmission

The best strategy for minimizing future influenza morbidity and mortality would be to concentrate vaccinations in school children and high-risk groups, according to a new research commentary by scientists at Emory University.

25 Jan 2005

Activate dendritic cells turn on biological clock

A molecule specially modified by researchers at Baylor College of Medicine can reset the biological clock for cancer vaccines, potentially making them more potent.

24 Jan 2005

ID Biomedical begins development of pandemic influenza vaccine

ID Biomedical announced today that it has begun development of an experimental ("mock") vaccine against a strain of the influenza virus, H5N1, that experts believe could cause a deadly worldwide epidemic (pandemic) of influenza.

19 Jan 2005

NIH begins Phase 1 clinical trial of HIV vaccine candidate

GenVec announced today that the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), has begun the second Phase 1 clinical trial in healthy adult volunteers of an HIV vaccine candidate jointly developed by the Dale and Betty Bumpers Vaccine Research Center (VRC), a part of NIAID, and GenVec.

19 Jan 2005